HR-8923-119
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What it does
This bill would create a 2-year demonstration program allowing hospitals to provide Medicare outpatient observation services in patients' homes rather than in a hospital setting. Participating hospitals would receive waivers from certain federal requirements — including on-premises 24-hour nursing and physical environment standards — and would be allowed to use telehealth from the patient's home. The Secretary of Health and Human Services would study and publicly report on quality, cost, and outcomes compared to traditional hospital observation care.
Who benefits
Medicare beneficiaries who prefer to recover at home rather than in a hospital, particularly elderly and mobility-limited patients. Hospitals that choose to participate and can reduce overhead costs. Home health agencies and telehealth companies that may provide services under hospital arrangements. Caregivers and family members who can be present during observation. Rural patients who live far from hospitals and may find home-based monitoring more accessible. Researchers and policymakers who would gain comparative data on home-based care models.
Who is hurt
Medicare beneficiaries who may face higher out-of-pocket costs, since observation status is billed as outpatient care — meaning patients may owe more for medications and follow-up skilled nursing facility care than they would under inpatient status. Hospital-based nurses, aides, and support staff whose workload or employment could shift if observation care moves out of facilities. Patients without reliable home environments, internet access, or live-in support who may be less suitable candidates but could face pressure to participate. Traditional inpatient facilities that may lose observation revenue to home-based competitors.
Supporters argue
Supporters argue that the COVID-19 pandemic's Acute Hospital Care at Home initiative demonstrated that hospital-level care can be delivered safely at home, with studies showing comparable or better outcomes and lower infection rates than facility-based care. They contend that home-based observation reduces unnecessary hospital exposure for Medicare's most vulnerable population, lowers costs for both the program and patients, and builds on an already-tested federal model — making a formal 2-year study a low-risk, evidence-generating step toward broader adoption.
Opponents argue
Opponents argue that the existing "observation status" framework already disadvantages Medicare beneficiaries by denying them inpatient protections, and that moving observation care into the home could deepen that gap — leaving patients responsible for drug costs and ineligible for covered skilled nursing facility stays. They contend that waiving 24-hour nursing and physical environment standards introduces patient safety risks that are difficult to monitor remotely, and that the program's voluntary, hospital-driven enrollment criteria could result in cherry-picking healthier patients, skewing outcome data and obscuring real-world risks for sicker beneficiaries.